Wang Xi, Hao Miao-Wang, Dong Ke, Lin Fang, Ren Ji-Hong, Zhang Hui-Zhong
Research Center, Tangdu Hospital, Fourth Military Medical University, Xi'an, China.
Arch Pharm Res. 2009 Sep;32(9):1263-9. doi: 10.1007/s12272-009-1912-8. Epub 2009 Sep 26.
Epigallocatechin-3-gallate (EGCG), the major component of green tea polyphenol, has potent efficiency to prevent the growth of a variety of cancer cells. As a novel anticancer agent for treatment of cancers, EGCG is promising and the mechanism has not been fully understood. Laryngeal squamous cell carcinoma (LSCC) is one common tumor in head and neck cancers. In the present study, we assess the effects of EGCG on LSCC cell line Hep-2, and their possible involvement in EGCG-induced apoptosis. The result showed that treatment of Hep-2 cells with EGCG decreased the cell viability, inhibited the growth and proliferation, induced apoptosis and increased the activity of caspase-3 in a dose-dependent manner. Furthermore, we found that EGCG-treatment repressed telomerase activity effectively in a concentration-dependent manner. The combined results show that EGCG induced apoptosis in Hep-2 cells via inhibiting the telomerase activity.
表没食子儿茶素-3-没食子酸酯(EGCG)是绿茶多酚的主要成分,具有预防多种癌细胞生长的强大功效。作为一种用于治疗癌症的新型抗癌剂,EGCG前景广阔,但其作用机制尚未完全明确。喉鳞状细胞癌(LSCC)是头颈癌中的一种常见肿瘤。在本研究中,我们评估了EGCG对LSCC细胞系Hep-2的影响,以及它们可能参与EGCG诱导的细胞凋亡的情况。结果表明,用EGCG处理Hep-2细胞会降低细胞活力,抑制生长和增殖,诱导细胞凋亡,并以剂量依赖的方式增加caspase-3的活性。此外,我们发现EGCG处理能以浓度依赖的方式有效抑制端粒酶活性。综合结果表明,EGCG通过抑制端粒酶活性诱导Hep-2细胞凋亡。